PrediSurge
PrediSurge is a French medical device software company that provides AI-powered digital twin technology for pre-operative planning of endovascular aortic repair procedures, serving vascular surgeons and stent graft manufacturers.
- Company typePrivate
- Founded2017
- HeadquartersSaint-Étienne, France
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What PrediSurge does
PrediSurge (SAS PREDISURGE) is a French medical device software company founded in 2017 and headquartered in Saint-Étienne, France, that develops an AI-powered digital twin platform for cardiovascular procedure planning. The company's core technology is an in-house U-Net deep learning architecture that performs automated segmentation of the aorta from standard CT scans, generating patient-specific digital twins used to plan endovascular aortic repair (EVAR) and fenestrated EVAR (FEVAR) procedures. Its commercial product suite, marketed under the PlanOp™ brand, includes iSizing (automated 100+ measurements per cross-section), the Endoleak Risk Index (an AI predictive model for Type 1A endoleak trained on 16,000 patient data points), the free CE-marked MPR View & Share DICOM viewer, and the Distance Colour Map visualization tool, all delivered via a cloud-based platform accessible from any web browser. The platform is CE-marked Class IIa (CE 0123), ISO 13485 and ISO 27001 certified, and holds EU MDR Quality Management certification.
PrediSurge serves two primary customer segments: vascular surgeons and interventional radiology teams at hospitals and academic medical centers (sold via per-seat SaaS subscriptions at €50–€150/user/month with a freemium MPR Viewer entry point), and medical device companies manufacturing aortic stent grafts (sold via OEM licensing, white-label embedding, and industrial R&D modules such as PlanOp Virtual Lab). The flagship commercial partnership is with Medtronic, whose SmartPlan Pro planning service is powered by PrediSurge's digital twin technology and was announced on January 30, 2025. The company has accumulated a 14-patent portfolio, 30 peer-reviewed scientific publications, 1,700+ patient-specific simulations executed, and adoption across approximately 250 clinical centers globally, supported by 11–50 employees and total funding of approximately €6.7 million across grants and equity rounds led by LIFTT and the European Innovation Council Fund.
PrediSurge firmographics
Firmographics- Name
- PrediSurge
- Legal name
- SAS PREDISURGE
- Website
- https://predisurge.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- PrediSurge is a French medical device software company that provides AI-powered digital twin technology for pre-operative planning of endovascular aortic repair procedures, serving vascular surgeons and stent graft manufacturers.
- Ownership category
- akta.pro rank
PrediSurge industry classification
Industry- Product category
- Cardiovascular Surgical Planning Software
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Surgical, Perioperative & ERAS Pathway Tools (HLACAGAJ)
- akta.pro secondary industries
- SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF), Risk Stratification, Early Warning Scores & Predictive Analytics (HLACAGAE)
Keywords
Where PrediSurge is headquartered
LocationHeadquarters
- HQ city
- Saint-Étienne
- HQ country
- France
- HQ region
- Europe
Offices1 record
Markets served
PrediSurge business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- SaaS Subscription (iSizing): PrediSurge's primary revenue stream is a SaaS subscription model, with per-seat pricing tiers (Basic at €50/user/month, Advanced at €150/user/month) and annual options. This provides recurring revenue from hospitals and vascular surgery departments using iSizing for pre-operative EVAR planning.
- Freemium / Free Viewer: The free MPR Viewer serves as a top-of-funnel freemium product, converting physicians to paid tiers and seeding platform adoption, while enterprise customers are driven through this freemium motion.
- OEM / Licensing (Medtronic): PrediSurge's technology is embedded within Medtronic's SmartPlan Pro service, generating licensing/OEM revenue from the integration of its digital twin platform into Medtronic's commercial stent graft planning ecosystem.
- Professional Services: Professional services including implementation support, training, and custom integration services are offered to enterprise customers such as medical device companies and large hospital networks.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Per seat | Monthly | iSizing Basic — entry-level EVAR sizing for individual physicians |
| Per seat | Annual | iSizing Basic Annual — discounted annual commitment |
| Per seat | Monthly | iSizing Advanced — high-volume EVAR sizing for teams |
| Per seat | Annual | iSizing Advanced Annual — discounted annual commitment |
| Subscription | Multi-year contract | Enterprise — custom pricing for large hospital systems and medical device companies |
| Freemium | Monthly | MPR Viewer — free freemium viewer |
Go-to-market motion4 records
Distribution channels3 records
Marketing channels6 records
PrediSurge product offering
Product offeringCore offering
PrediSurge develops and sells an AI-powered digital twin platform (PlanOp) for pre-operative planning of endovascular aortic repair (EVAR) procedures. The software automates aortic sizing by generating 100+ measurements per CT cross-section, predicts Type 1A endoleak risk using 16,000 data points, and delivers CE-marked (Class IIa) planning tools to vascular surgeons, hospitals, and medical device manufacturers.
Product overview
PrediSurge offers PlanOp™ AI as a unified cloud-based platform for cardiovascular intervention planning, comprising multiple integrated modules. The core patient care suite includes: MPR View & Share (free CE-marked DICOM viewer), iSizing (fully automated AI-powered sizing with 100+ measurements per cross-section), Endoleak Risk Index (ERI - AI predictive analytics for Type 1A endoleak using 16,000 data points), and Distance Colour Map (visual heatmap for graft apposition). PlanOp Aortic FEVAR handles complex fenestrated procedures. For medical device companies, PlanOp Virtual Lab and Try & Adopt enable R&D testing and clinical studies using patient-specific digital twins. SmartPlan Pro is a co-branded offering with Medtronic combining digital twin simulation with Endurant stent grafts.
Differentiator
Problem solved
Functional benefit
Brands
- PlanOp™: AI-powered digital twin platform for cardiovascular care planning, including patient care and next-gen solutions for clinicians and medical device companies
- iSizing
- MPR View & Share
- Endoleak Risk Index (ERI)
- PlanOp Aortic FEVAR
- SmartPlan Pro
- Distance Colour Map
- iView
Products and services
- MPR View & Share
Quantifiable outcome
- 80% sensitivity and 83% specificity in endoleak risk prediction (clinical validation study)
- +4 more outcomes
Companies that use PrediSurge
Customer profileNamed customers4 records
Segments2 records
Ideal customer profiles3 records
PrediSurge technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature6 records
PrediSurge partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered flagship / core and core.
- Medtronicflagship / corePrediSurge's AI-powered aortic digital twin technology powers Medtronic's SmartPlan Pro service, which is used for planning procedures with Medtronic's Endurant stent graft system. This is a flagship OEM embedding partnership — PrediSurge's software is integrated directly into Medtronic's commercial planning offering, reaching Medtronic's global installed base of Endurant customers. The collaboration was announced on January 30, 2025, and represents PrediSurge's most significant commercial partnership to date.
- EndoVx Consortium (Marie Lannelongue Hospital / Prof. Stephan Haulon)coreThe EndoVx Consortium is a clinical and research collaboration involving PrediSurge, Marie Lannelongue Hospital (a renowned French cardiac and vascular surgery center), and Prof. Stephan Haulon's team (a globally recognized vascular surgery key opinion leader). This consortium supports clinical validation, co-development of new digital twin features, and generation of peer-reviewed evidence for PrediSurge's platform.
Scale indicators6 records
Recent moves7 records
Expansion highlights6 records
PrediSurge competitors and assessment
Company assessmentDirect peers
- HeartFlow: HeartFlow provides AI-driven cardiovascular planning software (FFR-CT) for coronary artery disease, applying similar computational modeling and clinical decision support principles to PrediSurge's aortic digital twin approach. Both sell regulated AI planning tools to hospitals and physicians.
- RapidAI: RapidAI delivers AI-powered imaging analysis for stroke and vascular conditions, using deep learning on CT/CTA imaging to support time-critical clinical decisions. Overlaps with PrediSurge in AI vascular imaging analytics and hospital enterprise sales motion.
- Pie Medical Imaging: Pie Medical Imaging (now part of Esaote/Medis group) provides cardiovascular analysis software for CT, MRI, and angiography with strong presence in vascular procedure planning. Directly comparable in pre-operative measurement and planning workflows for vascular surgery.
- Medis Medical Imaging: Medis offers quantitative cardiovascular imaging analysis software used in routine clinical practice, including vessel sizing and post-processing comparable to PrediSurge's iSizing. Targets the same vascular surgery and cardiology customer base.
- CathWorks: CathWorks develops AI-based FFR assessment for coronary procedures using angiography imaging, sharing PrediSurge's model of AI-derived physiological and anatomical insights to guide device selection and procedural planning.
Emerging players
- Materialise: Materialise offers 3D medical planning software and patient-specific services, with an OEM/industrial channel to medical device manufacturers. Comparable to PrediSurge in serving both clinician planning workflows and medical device OEMs with custom digital-twin-style solutions.
- Viz.ai: Viz.ai applies AI to imaging workflows to accelerate clinical decision-making (notably stroke triage). Comparable to PrediSurge in regulated AI clinical decision support, though primarily in neurovascular rather than aortic applications.
Broad incumbents
- GE HealthCare: GE HealthCare is a global leader in imaging, PACS, and AI-augmented diagnostics with a broad cardiovascular portfolio. Already listed as a PrediSurge trusted partner, it represents both a partnership opportunity and a competitive threat if it bundles AI planning into its imaging suite.
- Siemens Healthineers: Siemens Healthineers offers AI-enabled cardiovascular imaging and syngo.via planning software across its installed base of CT and angiography systems. A broad incumbent whose AI cardiovascular roadmap overlaps with PrediSurge's planning scope.
- Philips: Philips provides integrated imaging, interventional guidance, and clinical informatics in cardiology and vascular care. Its enterprise hospital footprint and AI roadmap make it a comparable broad incumbent in cardiovascular procedure planning.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
PrediSurge social profiles
Digital presencePrediSurge compliance and trust
Trust signalCompliance5 records
PrediSurge financial estimates
Financial estimateRevenue estimate
Valuation estimate
PrediSurge leadership team
Management profileNumber of profiles
Profiles10 records
PrediSurge funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
PrediSurge M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about PrediSurge
What does PrediSurge do?
PrediSurge develops and sells an AI-powered digital twin platform (PlanOp) for pre-operative planning of endovascular aortic repair (EVAR) procedures. The software automates aortic sizing by generating 100+ measurements per CT cross-section, predicts Type 1A endoleak risk using 16,000 data points, and delivers CE-marked (Class IIa) planning tools to vascular surgeons, hospitals, and medical device manufacturers.
Is PrediSurge a public or private company?
PrediSurge is a private company. It is classified as venture growth investor backed and is currently operating.
When was PrediSurge founded?
PrediSurge was founded in 2017. It employs 11 to 50 people.
Where is PrediSurge based?
PrediSurge is headquartered in Saint-Étienne, France, in the Europe region.
How does PrediSurge make money?
Four revenue lines are on record. SaaS Subscription (iSizing) is the primary driver. The others are freemium / Free Viewer, OEM / Licensing (Medtronic) and professional Services.
Who are PrediSurge's main competitors?
Direct peers on record are HeartFlow, RapidAI, Pie Medical Imaging, Medis Medical Imaging and CathWorks. Emerging players are Materialise and Viz.ai. Broad incumbents are GE HealthCare, Siemens Healthineers and Philips.
Does PrediSurge have an API?
No public API is recorded for PrediSurge.
What industry is PrediSurge in?
PrediSurge's product category is Cardiovascular Surgical Planning Software. Its primary akta.pro industry code is HLACAGAJ, Surgical, Perioperative & ERAS Pathway Tools, with a secondary code of HLACANAF, SaMD – Digital Biomarkers & Algorithmic Endpoints. Its NAICS code is 334510 and its SIC code is 3841.